Vestcor Inc Regeneron Pharmaceuticals, Inc. Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vestcor Inc holds 21,590 shares of REGN stock, worth $15.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

21,590

Previous 20,936 3.12%

Holding current value

$15.4 Million

Previous $22 Million 3.14%

% of portfolio

0.72%

Previous 0.74%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$1024.09 - $1201.76 $669,754 - $785,951	654 Added 3.12%	21,590 $22.7 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $69,772 - $84,624	-79 Reduced 0.38%	20,936 $22 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $1 Million - $1.1 Million	-1,108 Reduced 5.01%	21,015 $20.2 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $930,215 - $1.06 Million	-1,200 Reduced 5.15%	22,123 $19.4 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $2.36 Million - $2.88 Million	-3,408 Reduced 12.75%	23,323 $19.2 Million
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $2.15 Million - $2.55 Million	3,069 Added 12.97%	26,731 $19.2 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $3.68 Million - $4.47 Million	-5,406 Reduced 18.6%	23,662 $19.4 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $6.4 Million - $6.95 Million	-9,069 Reduced 23.78%	29,068 $21 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $924,091 - $1.17 Million	-1,610 Reduced 4.05%	38,137 $26.3 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $795,655 - $1.07 Million	-1,451 Reduced 3.52%	39,747 $23.5 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $662,963 - $778,051	-1,114 Reduced 2.63%	41,198 $28.8 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $1.02 Million - $1.26 Million	1,885 Added 4.66%	42,312 $26.7 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1 Million - $1.19 Million	1,743 Added 4.51%	40,427 $24.5 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $6.11 Million - $7.22 Million	12,922 Added 50.16%	38,684 $21.6 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $1.26 Million - $1.55 Million	2,821 Added 12.3%	25,762 $12.2 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $517,998 - $658,442	1,083 Added 4.95%	22,941 $11.1 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $242,958 - $293,561	446 Added 2.08%	21,858 $12.2 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $9.72 Million - $12.7 Million	19,701 Added 1151.43%	21,412 $13.4 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $109,594 - $161,184	326 Added 23.54%	1,711 $835,000
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $379,670 - $521,466	1,385 New	1,385 $520,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account